Argent Biopharma (AU:RGT) has released an update.
Argent Biopharma Limited has announced the cessation of several securities due to the expiry of options and conditional rights. Specifically, 12,100 Performance Rights, 5,400 Class C Performance Rights, and 250 Class E Performance Rights have lapsed as conditions were not met or the options were not exercised. This change in the company’s issued capital could be of significant interest to investors monitoring Argent Biopharma’s financial movements.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
